Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantation (Q39702510)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantation	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantation (English)

1 reference

Europe PubMed Central

14 September 2017

2

object named as

Olle Korsgren

1 reference

Europe PubMed Central

14 September 2017

Gunnar Tufveson

5

object named as

Gunnar Tufveson

1 reference

Europe PubMed Central

14 September 2017

author name string

David Berglund

1

1 reference

Europe PubMed Central

14 September 2017

Tomas Lorant

3

1 reference

Europe PubMed Central

14 September 2017

Karin Schneider

4

1 reference

Europe PubMed Central

14 September 2017

Björn Carlsson

6

1 reference

Europe PubMed Central

14 September 2017

publication date

20 September 2011

1 reference

Europe PubMed Central

14 September 2017

Transplant Immunology

1 reference

Europe PubMed Central

14 September 2017

26

1 reference

Europe PubMed Central

14 September 2017

1

1 reference

Europe PubMed Central

14 September 2017

27-33

1 reference

Europe PubMed Central

14 September 2017

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Imbalance of regulatory T cells in human autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Natural regulatory T cells and parasites: a common quest for host homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Regulatory T cells in virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Regulatory T cells in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Regulatory T cells mediate maternal tolerance to the fetus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Immunology. Have you seen your mother, baby...

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Regulatory T cells and transplantation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Human T regulatory cell therapy: take a billion or so and call me in the morning

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

CD4+ T-regulatory cells: toward therapy for human diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

How regulatory T cells work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

How do regulatory T cells work?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Regulatory immune cell subsets in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

The expanding universe of regulatory T cell subsets in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

FOXP3+ regulatory T cells in the human immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Tr1 cells: from discovery to their clinical application.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Multiparameter immune profiling of operational tolerance in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

CD154 on the surface of CD4+CD25+ regulatory t cells contributes to skin transplant tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Tracking the immunoregulatory mechanisms active during allograft tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Regulatory T cells in transplantation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

IPEX and the role of Foxp3 in the development and function of human Tregs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Immunosuppressive drugs for kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants. Influence of Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Isolation of pure functionally active CD8+ T cells. Positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Adoptive regulatory T cell therapy: challenges in clinical transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Regulatory T cells as therapeutic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Human allograft acceptance is associated with immune regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Stability of the regulatory T cell lineage in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.09.003

7 January 2021

Identifiers

10.1016/J.TRIM.2011.09.003

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39702510&oldid=2089005237"